Related by context. All words. (Click for frequent words.) 72 Dalbavancin 71 Telbivudine 71 delafloxacin 70 Lubiprostone 70 Aliskiren 70 Radezolid 70 Nilotinib 69 BAL# [002] 69 Elagolix 69 Meets Primary Endpoint 69 Methylnaltrexone 69 Cethromycin 69 Pivotal Phase III 68 Adjuvant Treatment 68 Archexin 68 tigecycline 68 Phase 2b Clinical Trial 68 Phase 2a Clinical Trial 68 Oral Fingolimod 68 posaconazole 68 Inhalation Solution 68 PEGylated Fab fragment 68 Boceprevir 68 Denufosol 67 Phase IIb Clinical Trial 67 oral prodrug 67 quinolone 67 Tezampanel 67 Dasatinib 67 Achieves Primary Endpoint 67 Traficet EN 67 liposomal formulation 67 Investigational Compound 67 xanthine oxidase inhibitor 67 Enoxaparin 67 Phase III Clinical Trial 67 Clinical Trial Results 67 Aflibercept 67 radezolid 67 Pruvel 67 Fondaparinux 67 Vidofludimus 67 orally administered inhibitor 67 Daptomycin 67 vidofludimus 67 Clostridium difficile Infection 67 Ustekinumab 67 INCB# [003] 67 Patients Treated With 67 antiplatelet agent 67 DORIBAX 67 PEGylated anti 67 oral vancomycin 66 Cilostazol 66 methylnaltrexone bromide 66 Golimumab 66 candidemia 66 miconazole Lauriad ® 66 mu opioid receptor antagonist 66 Ecallantide 66 VAPRISOL 66 caspofungin 66 myelodysplastic myeloproliferative diseases 66 Adefovir 66 selective modulator 66 investigational humanized monoclonal antibody 66 Anidulafungin 66 Blinatumomab 66 trimethoprim sulfamethoxazole 66 Dapagliflozin 66 Bazedoxifene 66 CCX# 66 Patient Enrollment 66 ACTEMRA TM 66 Oritavancin 66 Bezielle 66 fluoroquinolone antibiotic 66 Levofloxacin 66 Panzem R 66 Pegloticase 66 CCX# B 66 JAK Inhibitor 66 Peginterferon alfa 2b 66 Pivotal Phase 66 oral renin inhibitor 66 Moxifloxacin 66 Tasimelteon 66 Tigecycline 66 Prulifloxacin 66 Carfilzomib 65 proteasome inhibitor 65 Civacir 65 Chemokine Receptor 65 selective kinase inhibitor 65 Single Dose 65 Ranolazine 65 Ozarelix 65 oropharyngeal candidiasis 65 Romiplostim 65 Phase III Trial 65 novel oral anticoagulant 65 Antitumor Activity 65 RECOTHROM R 65 Pivotal Clinical Trial 65 CIMZIA TM certolizumab pegol 65 Pivotal Trial 65 Hormone Refractory Prostate Cancer 65 CTAP# Capsules 65 TNF Tumor Necrosis Factor 65 Ambrisentan 65 Oral Mucositis 65 micafungin 65 Safinamide 65 CIMZIA TM 65 peripherally acting 65 Vandetanib 65 direct thrombin inhibitors 65 Vfend 65 endothelin receptor antagonists 65 herpetic keratitis 65 investigational pharmacologically unique 65 Factor VIIa 65 Percutaneous Tibial Nerve Stimulation 65 Pralatrexate 65 Vitro Activity 65 Altastaph 65 Unfractionated Heparin 65 Demonstrates Efficacy 65 Degarelix 65 Linaclotide 65 Raltegravir 65 ABILIFY ® 65 relapsed MM 65 ketolide antibiotic 65 OMNARIS HFA 65 investigational monoclonal antibody 65 Liposomal 65 acetonide FA 65 Pafuramidine 65 Novel Antibiotic 65 pseudobulbar affect PBA 65 Rigel R# 65 Anti Tumor Activity 65 Microplasmin 65 SinuNase TM 65 Fulvestrant 65 Fluconazole 65 Exemestane 65 Pirfenidone 65 Vaccine Candidate 65 receptor tyrosine kinase inhibitor 65 MYCAMINE 65 nucleoside analog 65 NAVISTAR R 65 hematological parameters 65 Proquin XR 64 sorafenib Nexavar 64 TYGACIL 64 Glatiramer Acetate 64 Novel Inhibitor 64 vapreotide acetate 64 Intravitreal 64 amphotericin B 64 5 HT3 antagonist 64 Cetrorelix 64 Capecitabine 64 Gleevec resistant 64 CYT# QbG# 64 liposomal amphotericin B 64 LHRH antagonists 64 CINQUIL 64 Q#IR 64 Phase IIb Trial 64 NDA Submission 64 diarrhea predominant irritable 64 LymphoStat B belimumab 64 Personalized Immunotherapy 64 MOVIPREP R 64 Natalizumab 64 Investigational Treatment 64 PRT# 64 Ziprasidone 64 MDS MPD 64 nasal spray formulation 64 diabetic gastroparesis 64 lucinactant 64 Adjunctive 64 docetaxel Taxotere ® 64 Elesclomol 64 Zorbtive TM 64 invasive aspergillosis 64 acute peripheral arterial 64 ARCOXIA 64 Ramoplanin 64 Eculizumab 64 torezolid phosphate 64 Study Evaluating 64 Completes Patient Enrollment 64 Carvedilol 64 Belimumab 64 acyclovir Lauriad R 64 riociguat 64 hyperphenylalaninemia HPA due 64 Pharmacokinetic Study 64 Bosutinib 64 Lenalidomide 64 Prolongs Survival 64 nitrofurantoin 64 IRX 2 64 BCR ABL inhibitor 64 Cyclosporine 64 Alfimeprase 64 Receives Orphan Drug Designation 64 therapeutically inactive prodrug 64 Avanafil 64 CYT# potent vascular disrupting 64 Amrubicin 64 Erlotinib 64 Complicated Skin 64 Aganocide 64 voriconazole 64 Pharmacokinetics PK 64 unfractionated heparin UFH 64 Perifosine 64 Trial Evaluating 64 Tesetaxel 64 Molecular Weight Heparin 64 ALVESCO 64 superficial bladder cancer 64 Tyrosine Kinase Inhibitor 64 ZOLINZA 64 Pivotal Study 64 selective androgen receptor modulator 64 ADP receptor antagonist 64 demethylation agents 64 Temsirolimus 64 echinocandin 64 fosbretabulin 64 TREDAPTIVE 64 Panzem R NCD 64 Drug Candidate 64 CCR5 antagonist 64 RhuDex ® 64 PEGylated interferon beta 1a 64 Rivaroxaban 64 MTP inhibitor 64 Bucindolol 64 Interferon beta 1b 64 Laquinimod 64 sorafenib tablets 64 Glufosfamide 64 RNAi Therapeutic 64 Itraconazole 64 Phase 2b Trial 64 Novel Oral 64 Omacetaxine 64 Mg Usa 64 Tolvaptan 64 Mg Uk 64 Protease Inhibitors 64 somatostatin analogue 64 See CLINICAL PHARMACOLOGY 64 efficacy tolerability 64 Simulect 64 Monotherapy 64 Squalamine 64 Overactive Bladder 64 Bortezomib 64 Alfacell proprietary ribonuclease 64 Ophena TM 64 oral rivaroxaban 64 Tamibarotene 64 invasive candidiasis 64 Antiviral Activity 63 MAGE A3 ASCI 63 Naive Patients 63 Vicriviroc 63 Noxafil 63 Mipomersen 63 interferon gamma 1b 63 reslizumab 63 LT NS# 63 Iloperidone 63 Sitagliptin 63 Sym# 63 ALN TTR 63 antibody MAb 63 Hsp# Inhibitor 63 Aurora Kinase 63 TRX1 63 PNP inhibitor 63 Vascugel 63 Mitoxantrone 63 Tesamorelin 63 Altabax 63 Interferon Beta 63 6R BH4 63 FDA Approvals 63 beta 1a 63 evaluating tivozanib 63 Preclinical Data 63 Ofatumumab 63 FOLOTYN ® 63 Factor Xa inhibitor 63 diabetic neuropathic pain 63 Fludara ® 63 Pertuzumab 63 First Patient Dosed 63 Combination Therapy 63 Octreolin 63 Pooled Analysis 63 CANCIDAS 63 SERMs 63 Posaconazole 63 Dabigatran etexilate 63 antiviral efficacy 63 Epratuzumab 63 HuMax CD4 63 Metastatic Melanoma 63 Bivalirudin 63 Tiotropium 63 Candesartan 63 LNPs 63 Clevudine 63 immunotherapeutic agent 63 Combination therapy 63 Voreloxin 63 Oral Insulin 63 Talabostat 63 SUTENT ® 63 Recombinant Human 63 Severe Sepsis 63 imipenem 63 somatostatin analog 63 Chemophase 63 Xanafide 63 LibiGel ® 63 Phase III Pivotal Trial 63 trospium 63 BENICAR HCT 63 Peginterferon 63 CYP#A# CYP#D# 63 Efficacy Results 63 Icatibant 63 Naproxcinod 63 protein tyrosine phosphatase 1B 63 Clinical Efficacy 63 overactive bladder syndrome 63 Clinical Trial Evaluating 63 Tyrima 63 Mycophenolate Mofetil 63 M# rationally 63 Soliris eculizumab 63 rasagiline tablets 63 TPI ASM8 63 novel histone deacetylase 63 Daclizumab 63 Diabetic Neuropathy 63 TYZEKA 63 HDAC Inhibitor 63 ALGRX 63 Tocilizumab 63 basiliximab 63 octreotide acetate 63 uricase 63 ChronVac C R 63 ALVESCO ® 63 Actemra tocilizumab 63 R lenalidomide 63 calcineurin inhibitors 63 Randomized Phase 63 Immunogenicity 63 Disease Progression 63 Adalimumab 63 Metastatic Prostate Cancer 63 liposome injection 63 FDA Accepts 63 Milnacipran 63 equine osteoarthritis 63 Phase 2a Trial 63 small molecule tyrosine 63 LEVAQUIN ® 63 MabCampath 63 Firazyr 63 Ticagrelor 63 alpha blocker 63 Presents Preclinical Data 63 TBC# 63 Non inferiority 63 Relapsing Remitting Multiple Sclerosis 63 Teriflunomide 63 CTAP# 63 Tolerability 63 Arikace 63 Maribavir 63 Pegylated Liposomal Doxorubicin 63 CorVue ™ 63 Initiates Clinical Trial 63 immunomodulatory therapy 63 Combination REOLYSIN R 63 Dose Escalation 63 Saxagliptin 63 Phase 2a Study 63 Apixaban 63 pegylated 63 dexlansoprazole 63 Phase III Pivotal 63 Loxapine 63 platelet inhibitor 63 amikacin 63 mRCC 63 reduce serum phosphate 63 corticosteroid dexamethasone 63 Intranasal 63 Thiovir 63 serotonin norepinephrine reuptake inhibitor 63 alvimopan 63 brand ciclesonide HFA 63 OHR/AVR# 63 Hepatocellular Carcinoma 63 Tofacitinib 63 CIMZIA ™ 63 macrolide antibiotic 63 topically applied SEPA 63 Efficacy Trial 63 toenail onychomycosis 63 sodium glucose cotransporter 63 Fungal Infections 63 DOXIL 63 Ocrelizumab 63 Shows Statistically Significant 63 CEQ# 62 Initiate Clinical Trial 62 Aurexis 62 Interferon alpha 62 Dabigatran 62 Demonstrates Sustained 62 ara C 62 nucleoside reverse transcriptase inhibitor 62 Initiate Phase 62 NOXAFIL 62 Bosentan 62 Ridaforolimus 62 Doxil ® 62 Muraglitazar 62 dopamine partial agonist 62 monoclonal antibody conjugated 62 REP# 62 Mycamine 62 BAY #-# 62 R Saizen R 62 Initiates Clinical 62 Pemetrexed 62 Aptivus ® 62 Alvesco R 62 RAPAFLO R 62 forodesine 62 Interferon Alfa 62 Zoraxel TM 62 Placebo Controlled Trial 62 5 HT2A receptor 62 candidate XP# 62 Hepatic Encephalopathy 62 Anturol TM 62 INVEGA ® 62 Clolar ® 62 Cleviprex TM clevidipine 62 ceftazidime 62 NXL# 62 investigational antiplatelet agent 62 gastrointestinal stromal tumors GIST 62 Nexavar ® 62 Medoxomil 62 UPLYSO 62 biologic DMARD 62 Replacement Therapy 62 delta isoform 62 aripiprazole Abilify 62 dasatinib Sprycel 62 Chronic Heart Failure 62 rilonacept 62 Demonstrates Positive 62 ULORIC 62 Afatinib 62 Phase IIb clinical trials 62 LAB CGRP 62 Inhalation Aerosol 62 echinocandins 62 KETEK 62 HCV Protease Inhibitor 62 Dyloject TM 62 Parathyroid Hormone 62 Everolimus 62 Roflumilast 62 Stent Restenosis 62 Liprotamase 62 adalimumab Humira 62 headache abdominal pain 62 PDE4 inhibitors 62 Infected Patients 62 EGFR TKI 62 AAG geldanamycin analog 62 Sudhir Agrawal D.Phil 62 Certolizumab 62 CYPHER R Sirolimus Eluting 62 Angiotensin Converting Enzyme 62 virus HCV protease inhibitor 62 DEXILANT 62 STRIDE PD 62 inhibitor RG# 62 Cancidas 62 Intravesical 62 investigational antibiotic 62 APTIVUS r 62 Darusentan 62 INT# [002] 62 teriflunomide 62 SNT MC# 62 Completes Enrollment 62 Abbott HUMIRA 62 Receives Orphan Drug 62 selective agonist 62 Immunotherapeutic 62 Demonstrates Significant 62 Investigational Drug 62 non porcine pancreatic 62 anidulafungin 62 Relapsing Multiple Sclerosis 62 INCB# [001] 62 Telaprevir 62 Pazopanib 62 Symadex 62 Vildagliptin 62 infliximab Remicade 62 INSPIRE Trial Phase III 62 Files IND 62 Duloxetine 62 Sanvar R 62 Decitabine 62 Capesaris 62 Vidaza azacitidine 62 Initiates Enrollment 62 Ceftobiprole 62 CRMD# 62 Prospective Randomized 62 Initiate Phase III 62 dasatinib Sprycel ® 62 humanized monoclonal 62 occlusion PAO 62 Biolimus A9 62 Plicera 62 glatiramer acetate 62 HES CEL 62 Pediatric Patients 62 dosing frequency 62 Omalizumab 62 angiotensin II receptor blocker 62 Darinaparsin 62 pharmacokinetic equivalence 62 PDE4 inhibitor 62 DACH platinum 62 Submits NDA 62 Deforolimus 62 Unresectable 62 calcineurin inhibitor 62 Melphalan 62 Lacosamide 62 LOVENOX R 62 Cyclooxygenase 2 62 OMNARIS Nasal Spray 62 inhaled formulation 62 Long Term Efficacy 62 Late Breaker 62 ganetespib 62 ARIKACE 62 GORE VIABAHN Endoprosthesis 62 Investigational Agent 62 pioglitazone HCl 62 alpha 2a 62 Zingo TM 62 pan HDAC inhibitor 62 Oracea TM 62 CG# [003] 62 pegylated interferon alfa 62 YONDELIS 62 Humanized Anti 62 Pradefovir 62 FUSILEV enhances 62 Xcytrin R 62 abacavir lamivudine 62 analgesic efficacy 62 Hepatitis C Virus HCV 62 Bevacizumab 62 ORENCIA R 62 esophageal candidiasis 62 Fludarabine 62 #mg BID [001] 62 ibuprofen Injection 62 aldosterone antagonists 62 Isavuconazole 62 cinacalcet 62 Immune Responses 62 5 Fluorouracil 62 LEUKINE 62 Evoltra ® 62 recombinant interferon 62 phase IIb clinical 62 novel VDA molecule 62 molecular weight heparins 62 Virologic 62 Regenerative Cells 62 EVIZON TM 62 Double Blind Placebo 62 salmeterol fluticasone 62 Orally administered 62 rNAPc2 62 humanized anti 62 Certolizumab pegol 62 NS#/#A protease 62 lomitapide 62 icatibant 62 colesevelam 62 Kamada AAT 62 administered subcutaneously 62 Pulmonary Arterial Hypertension 62 Rheumatoid Arthritis Patients 62 generation purine nucleoside 62 Oral Spray 62 multi kinase inhibitor 62 antitumor efficacy 62 Phase 2b Study 62 iclaprim 62 chemotherapy induced neutropenia 62 Copegus ribavirin 62 angiotensin receptor blocker ARB 62 class mGluR5 inhibitor 62 Phase 1b Clinical Trial 62 delivers fluocinolone acetonide FA 62 Tumor Response 62 Levetiracetam 62 thetreatment 62 Ciclesonide 62 NeuroSTAT ® 62 oxidative stress inducer 62 OvaRex R 61 standard chemotherapy regimen 61 IMiDs ® compound 61 Tanespimycin 61 Interferon alfa 61 anti angiogenic agent 61 TAXUS Stent 61 allosteric modulator NAM 61 Gamunex C 61 SPIRIVA ® 61 Renal Cell Carcinoma 61 MKC# MKC# PP 61 Acute Ischemic Stroke 61 Virulizin ® 61 IND Application 61 AVAPRO 61 Granted Orphan Drug 61 QLT# 61 BARACLUDE R 61 Eluting Coronary Stent System 61 Fluvastatin 61 Nebulized 61 R roscovitine 61 Phase III Clinical Trials 61 TRV# [001] 61 bronchodilatory 61 Chronic Hepatitis B 61 cannabinor 61 XYOTAX TM 61 Indaflex TM 61 AGILECT R 61 abacavir Ziagen 61 levodopa carbidopa 61 tipranavir 61 Relapsed Multiple Myeloma 61 KRN# 61 Clinical Outcome 61 bosutinib 61 Chronic Hepatitis C 61 Tipranavir 61 vitreoretinal disorders 61 Romidepsin 61 baminercept 61 TEMODAL 61 Metastatic Renal Cell Carcinoma 61 candidate TNFerade biologic 61 HCV protease inhibitors 61 Trastuzumab 61 radiation sensitizer 61 Shows Efficacy 61 orally inhaled migraine 61 Eszopiclone 61 antithrombotics 61 Elotuzumab 61 Genasense ® 61 immunotherapeutic vaccine 61 recurrent genital herpes 61 Alemtuzumab 61 Amgen Neulasta R 61 Begins Dosing 61 ORENCIA ® 61 Fibrillex TM 61 Surgical resection 61 Cardiotoxicity 61 pancreatic insufficiency 61 CCR9 antagonist 61 Reports Preclinical Data 61 torezolid 61 selective A2A adenosine receptor 61 Telavancin 61 dexamethasone Decadron 61 JAK inhibitor 61 Cellegesic 61 Sapacitabine 61 EZN 61 Ganciclovir 61 aprepitant 61 Lung Cancer Trial 61 Zoloft sertraline 61 mTOR inhibitor 61 Patients Receiving 61 Controlled Study 61 non nucleoside inhibitor 61 Castration Resistant Prostate Cancer 61 calcipotriene 61 Extended Release 61 Spiegelmer ® 61 bleeding pallor 61 Pathway Inhibitor 61 Novel Compound 61 PEGylated 61 IMiDs ® 61 direct renin inhibitor 61 experimental immunotherapeutics antivirals AmpligeGI mucosa resulting 61 endothelin receptor 61 Fluticasone 61 adefovir dipivoxil 61 Lupus Drug 61 Antitumor 61 gastrointestinal toxicity 61 ZYVOX 61 DU #b 61 IND Filing 61 Irinotecan 61 PEG IFN 61 treat chronic sinusitis 61 prucalopride 61 hemodynamically significant 61 tezampanel 61 nephrotoxicity 61 imatinib Gleevec ® 61 Phase III Trials 61 Zavesca R 61 Anti Tumor 61 IMA# 61 alfuzosin 61 XmAb# 61 Bavituximab 61 HuMax EGFr 61 Resten NG 61 erlotinib Tarceva ® 61 castrate resistant prostate cancer 61 Carotid Stenting 61 Metastatic Colorectal Cancer 61 antiepileptics 61 reverse transcriptase inhibitor 61 alfa 2a 61 VISICOL R 61 itraconazole Sporanox 61 velafermin 61 RhuDex TM 61 Anticancer Activity 61 Paraplatin ® 61 atovaquone 61 Cimzia TM 61 Azacitidine 61 palonosetron 61 Advanced Melanoma 61 ritonavir boosted 61 dose proportional pharmacokinetics 61 azoles 61 edifoligide 61 oropharyngeal candidiasis OPC 61 targeted radiotherapeutic 61 Zenvia Phase III 61 viral kinetics 61 mapatumumab 61 LEP ETU 61 Pivotal Phase II 61 AEGR 61 Efficacious 61 mecamylamine 61 nosocomial pneumonia 61 Preclinical studies suggest 61 Losartan 61 olmesartan medoxomil hydrochlorothiazide 61 PROMACTA 61 HQK 61 renin inhibitor 61 prescribed proton pump 61 EXPAREL ™ 61 Improved Survival 61 Guanilib 61 HZT 61 lexidronam injection 61 hypereosinophilic syndrome 61 Double Blind Randomized 61 TroVax ® 61 Well Tolerated 61 MYDICAR ® 61 ergot derivatives 61 zidovudine AZT 61 registrational trial 61 antiarrhythmic drugs 61 decitabine 61 Cytotoxicity 61 BRIM2 61 dosage regimens 61 IL# PE#QQR 61 RAPAFLO 61 thalidomide Thalomid 61 BENLYSTA TM 61 Patent Covering 61 SNRI 61 Neulasta ® 61 ganciclovir 61 Locteron 61 oral anticoagulant 61 idarubicin 61 refractory gout 61 intranasal formulation 61 XP# XP# 61 CIMZIA R 61 FASLODEX 61 targeting CD# 61 Phase Ib study 61 Treated Patients 61 antiplatelet compound 61 BROVANA 61 Mitomycin C 61 atacicept 61 LUVENIQ 61 Maraviroc 61 microbiological eradication 61 Atopic Dermatitis 61 FOLFOX6 61 epigenetic therapies 61 ARCALYST ® 61 amprenavir 61 Initiates Phase II 61 Zenvia ™ 61 metaglidasen 61 Durezol 61 BRAF inhibitor 61 rFIXFc 61 tapentadol ER 61 Indacaterol 61 Onalta 61 JAK2 Inhibitor 61 VIVITROL ® 61 ADAGIO study 61 oral dual endothelin 61 motexafin gadolinium Injection 61 morphometric vertebral fractures 61 APTIVUS 61 PROVENGE sipuleucel T 61 Presents Positive 61 antiplatelet agents 61 tolerability profiles 61 Pegylated 61 ESBA# 61 Fabry Disease 61 either acutely decompensated 61 pharmacokinetic PK study 61 Survival Benefit 61 systemic fungal infections 61 Navelbine ® 61 FDA Approvable Letter 61 Elvitegravir 61 Dose Ranging Study 61 Aclidinium 61 cidofovir 61 Accelerated Approval 61 Valsartan 61 azelastine 61 Fast Track Status 61 Onconase 61 Pegylated Interferon 61 Protease Inhibitor 61 OvaRex ® MAb 61 Perforomist ™ Inhalation Solution 61 AEG# 61 Octreotide 61 ALN PCS 61 fluticasone furoate 61 Zoledronic acid 61 Toxicities 61 PEG SN# 61 Xeloda ® 61 II Clinical Trial 61 systemic RNAi therapeutic 61 INC# 61 thromboprophylaxis 61 severe gastroparesis 61 Lenocta 61 Bare Metal Stent 61 TKB# 61 Improves Survival 61 Pimavanserin 61 clevidipine 61 targeted antifolate 61 Telatinib 61 biologic therapy 61 thienopyridines 61 Hycamtin ® 61 PRTX 61 RLY# 61 Telithromycin 61 intravenous formulations 61 pegfilgrastim 61 Randomized Clinical Trials 61 Placebo Controlled Study 61 Darunavir 61 Demonstrate Significant 60 IAP inhibitor 60 transcriptase inhibitor NNRTI 60 Orally Active 60 Pegasys ® 60 pharmacologic agents 60 Oral Calcitonin 60 ruxolitinib 60 Azedra 60 nucleotide analog 60 Statistically Significant 60 CA4P 60 ALVESCO R 60 potent CYP#A# inhibitors 60 telbivudine 60 SCH # 60 denileukin diftitox 60 SinuNase ™ 60 administered concomitantly 60 mTOR inhibitors 60 clodronate 60 BEMA TM Fentanyl 60 Zileuton 60 Adjuvant Therapy 60 highly purified pasteurized 60 compound INCB# 60 dextromethorphan quinidine 60 Desvenlafaxine Succinate 60 orally inhaled 60 miconazole Lauriad R 60 severe hypercholesterolemia 60 canakinumab 60 Eltrombopag 60 LEVADEX ™ 60 ethambutol 60 Letairis ambrisentan 60 VFEND 60 EOquin 60 EndoTAG TM -1 60 Starlix 60 Autologous Stem Cell Transplantation 60 Demonstrated Significant 60 fluvastatin 60 Previously Treated 60 Nexavar sorafenib 60 Randomized Evaluation 60 Etanercept 60 TORISEL 60 tocilizumab 60 Torisel 60 direct thrombin inhibitor 60 inhaled liposomal ciprofloxacin 60 Quetiapine 60 Vaprisol 60 Patients Treated 60 Drug Eluting Stents 60 MEK Inhibitor 60 BYSTOLIC 60 Aryplase 60 Interferon Gamma 60 Arixtra 60 ribavirin RBV 60 PRN FDA Approves 60 ximelagatran 60 Topotecan 60 volociximab 60 mGluR5 NAM 60 RAPTIVA 60 tyrosine kinase inhibitor 60 sunitinib Sutent ® 60 histone deacetylase HDAC inhibitor 60 Zolinza